-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, P10WOS+vk9av+80jyxsTcpi159WWxmyVUuKAg5Tz+CUVfap5wFfWqqvhUYODPcwz WjGG8DN1JUhX+om5Ihyddg== 0000891092-03-002474.txt : 20030915 0000891092-03-002474.hdr.sgml : 20030915 20030915132044 ACCESSION NUMBER: 0000891092-03-002474 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20030912 ITEM INFORMATION: Other events FILED AS OF DATE: 20030915 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIFAST INC CENTRAL INDEX KEY: 0000910329 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS [2090] IRS NUMBER: 133714405 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31573 FILM NUMBER: 03895257 BUSINESS ADDRESS: STREET 1: 11445 CRONHILL DRIVE CITY: OWINGS MILLS STATE: MD ZIP: 21117 BUSINESS PHONE: 7327640619 MAIL ADDRESS: STREET 1: 11445 CRONHILL DRIVE CITY: OWINGS MILLS STATE: MD ZIP: 21117 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHRITE INC DATE OF NAME CHANGE: 19951120 FORMER COMPANY: FORMER CONFORMED NAME: XX DATE OF NAME CHANGE: 19950619 FORMER COMPANY: FORMER CONFORMED NAME: 00 DATE OF NAME CHANGE: 19950619 8-K 1 e15682_8k.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 12, 2003 MEDIFAST, INC. (Exact name of registrant as specified in its charter) Delaware 000-23016 13-3714405 - --------------------------------- ------------------------ ------------- (State or other jurisdiction (Commission File Number) (IRS Employer of incorporation or organization) Ident. No.) 11445 Cronhill Drive, Owings Mills, Maryland 21117 -------------------------------------------- ---------- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (410)-581-8042 ________________________________________________________________________________ (Former name or former address, if changed since last report.) ___________________________________________________ ___________________________________________________ Item 5. Other Events Seven Crondall, LLC, a wholly owned subsidiary of Medifast, Inc. ("Company") (AMEX:MED) has purchased a 119,825 sq. foot distribution facility located at 601 Sunrise Ave., Ridgely, Maryland 21660 from NewRoads, Inc. for $2.6 million. The company will finance $1.7 million through Merrill Lynch Capital at the 30 day LIBOR interest rate plus 220 basis points over seven years. The Company also acquired the assets and management expertise of Dunst and Associates, Inc., a 15-year experienced distributor in Eldersburg, Maryland to operate the new distribution center. The company acquired Dunst and Associates assets for $400,000 in cash and 3,347 shares of Medifast common stock, which will provide the infrastructure necessary to continue operations without interruption since Dunst and Associates currently handles 50% of the pick and pack distribution business for Medifast. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MEDIFAST, INC. Dated: September 12, 2003 /s/ Bradley T. MacDonald ------------------------------------ Bradley T. MacDonald Chairman and Chief Executive Officer 2 EX-99.1 3 e15682ex99-1.txt PRESS RELEASE Exhibit 99.1 Medifast Acquires New Distribution Facility and 15-year-old Distribution Team OWINGS MILLS, Md., Sept. 15 /PRNewswire-FirstCall/ -- Medifast, Inc. (Amex: MED) announced today that Seven Crondall, LLC, a wholly owned subsidiary of Medifast, has completed the purchase of a 119,000 square foot distribution facility in Ridgley, Maryland. The agreement between the Company and NewRoads, Inc. was finalized today at a purchase price of $2.6 million. The Company will finance $1.7 million through Merrill Lynch Capital at the 30 day LIBOR interest rate plus 220 basis points over the next seven years. The distribution facility is expected to help the Company, through its capacity to produce up to $200 million per year in Medifast products, to support the company's growth objectives. Medifast also acquired the assets and management expertise of Dunst and Associates, Inc., (Dunst) a Maryland Corporation. The Company purchased the 15-year-old distributor for $400,000 in cash and 3,347 shares of Medifast common stock. The purchase will provide the management and infrastructure necessary to continue operations without interruption, since Dunst currently handles 50% of the pick and pack distribution business for the Company. "Acquiring the assets of Dunst will allow us to improve the level of service our customers receive," says Brad MacDonald, Medifast's CEO. "With Dunst's expertise and our new facility, our Company will have the opportunity to expand its infrastructure to accommodate our anticipated growth and maintain the quality of products that our customers have come to expect. This is another step in developing the resources necessary to support the dramatic increase in sales we expect will be generated by our 2004 national television, print and radio advertising campaign." The Company recently assembled its first "second shift" manufacturing team since 1993, to increase inventories to support its current level of business. This release contains forward-looking statements, which may involve known, and unknown risks, uncertainties and other factors that may cause Medifast's actual results and performance in future periods to be materially different from any future results or performance suggested by these statements. Medifast cautions investors not to place undue reliance on forward-looking statements, which speak only to management's expectation on this date. SOURCE Medifast, Inc. /CONTACT: Jeremy Hunt, Investor Relations Specialist, +1-410-504-8196 or Casey Seward, Public Relations and Marketing Manager, +1-410-504-8154, both of Medifast, Inc.; or Ken Sgro of CEOcast, Inc. for Medifast, +1-212-732-4300/ /Web site: http://www.medifast.net/ (MED) CO: Medifast, Inc.; NewRoads, Inc.; Seven Crondall, LLC; Dunst and Associates, Inc. ST: Maryland IN: HEA SPM SU: TNM -----END PRIVACY-ENHANCED MESSAGE-----